Tigecycline Soft Tissue Penetration in Obese and Non-obese Surgical Patients Determined by Using In  Vivo Microdialysis

ConclusionFollowing a single dose of tigecycline, concentrations in the ISF of subcutaneous adipose tissue are decreased in heavily obese subjects, calling for an increased loading dose.EU Clinical Trials Registration NumberEudraCT No. 2012-004383-22.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research